vester_guy, the 1:25 R/S didn't burn you. If this company was a healthy successful company, that would not have mattered.
What burned you was believing Garza and believing the CEO's press releases and believing Silvani. If you had just read the SEC filings you would have seen the truth: losing Jade was a death knell. Without Jade, this company could only generate enough gross revenues to cover about 5% of operating costs.
That is an unsustainable business model. To put it mildly.
Even in the remote possibility that some entity was considering a merger with or takeover of Radient, a quick glance at the SEC filings would put an end to that plan quickly. It's cheap to license DR-70 and try to sell it, and then if you fail, oh well. But to buy the company and then fail to sell it would be disastrous to the acquiring entity.
Companies like Astellas and Fortis don't become successful by buying zombie biotechs. Provista saw that DR-70 was a failure and kicked it to the curb in 2011, and it looks like they kicked Gartner to the curb at the same time, although we will never know exactly what happened there.
But if you stop looking in the rear-view mirror and look at Radient today, you see a non-operational shell with a lot of debt and no assets. Doesn't take a genius to realize that there will be no merger or takeover.
